Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic.
Adolescent
Alberta
/ epidemiology
Blood Glucose Self-Monitoring
/ statistics & numerical data
COVID-19
/ epidemiology
Child
Child, Preschool
Diabetes Mellitus, Type 1
/ diagnosis
Diabetic Ketoacidosis
/ diagnosis
Female
Humans
Intensive Care Units, Pediatric
/ statistics & numerical data
Male
Pandemics
Retrospective Studies
SARS-CoV-2
COVID-19
Children
diabetes
diabetic ketoacidosis
pandemic
Journal
Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
02
02
2021
received:
26
11
2020
accepted:
06
03
2021
pubmed:
22
3
2021
medline:
13
5
2021
entrez:
21
3
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has led to significant public health measures that have resulted in decreased acute pediatric care utilization. We evaluated whether the rate of severe presentations of new onset type 1 diabetes (DM1), such as, diabetic ketoacidosis (DKA) has changed since the COVID-19 public health measures were enacted. A retrospective chart review of children less than 18 years of age presenting with new onset DM1 during the pandemic period of March 17, 2020 to August 31, 2020 was conducted at two tertiary care pediatric hospitals in Alberta, Canada. Rates of DKA and severe DKA were compared to the same time period in the year 2019 (pre-pandemic control). The number of children presenting with newly diagnosed DM1 was similar during the pandemic year of 2020 compared with 2019 (107 children in 2020 vs. 114 in 2019). The frequency of DKA at DM1 onset was significantly higher in the pandemic period (68.2% vs 45.6%; p < 0.001) and incidence of severe DKA was also higher (27.1% in 2020 vs 13.2% in 2019; p = 0.01). There was a significant increase in DKA and severe DKA in children presenting with new onset DM1 during the COVID-19 pandemic period. This emphasizes the need for educating health care professionals and families to be aware of the symptoms of hyperglycemia and the importance of early diagnosis and treatment even during public health measures for COVID-19.
Identifiants
pubmed: 33745226
doi: 10.1111/pedi.13205
pmc: PMC8251027
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
552-557Informations de copyright
© 2021 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Références
CMAJ Open. 2019 May 14;7(2):E300-E305
pubmed: 31088804
Pediatr Clin North Am. 2015 Aug;62(4):857-71
pubmed: 26210621
JAMA. 2020 Aug 25;324(8):801-804
pubmed: 32702751
Pediatr Diabetes. 2021 Jun;22(4):552-557
pubmed: 33745226
Diabetes Care. 2020 Jan;43(1):117-121
pubmed: 31601639
Can J Diabetes. 2018 Apr;42 Suppl 1:S10-S15
pubmed: 29650080
Pediatrics. 2014 Apr;133(4):e938-45
pubmed: 24685959
Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177
pubmed: 29900641
Pediatr Diabetes. 2018 May;19(3):501-505
pubmed: 28857360
Arch Dis Child. 2020 Jul;105(7):704
pubmed: 32376695
Diabet Med. 2021 Jan;38(1):e14417
pubmed: 33020999
Diabetes Care. 2020 Nov;43(11):e172-e173
pubmed: 32826282
Diabetes Care. 2020 Nov;43(11):e170-e171
pubmed: 32816997
J Pediatr. 2010 Mar;156(3):472-7
pubmed: 19962155
Can J Diabetes. 2018 Apr;42 Suppl 1:S109-S114
pubmed: 29650082
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Pediatr Diabetes. 2012 Dec;13(8):647-51
pubmed: 22816992
Diabetes Care. 1999 Jan;22(1):7-9
pubmed: 10333896
Diabetes Care. 2020 Nov;43(11):2870-2872
pubmed: 32778554
Diabetes Care. 2017 Sep;40(9):1249-1255
pubmed: 28667128
CMAJ. 2020 Aug 10;192(32):E921-E927
pubmed: 32586838
Pediatr Diabetes. 2020 Nov;21(7):1083-1092
pubmed: 32686287